Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

Posted on by

Lancet Infectious Diseases
Apr 2020 Volume 20 Number 4 p383-510, e50-e78
http://www.thelancet.com/journals/laninf/issue/current

 

Articles
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
David Liebowitz, et al.